XML 50 R35.htm IDEA: XBRL DOCUMENT
v3.6.0.2

BUSINESS ACQUISITIONS (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2016
Business Combinations [Abstract] |
Schedule of Purchase Price Allocation | The following tables summarize the total consideration and the amounts of assets acquired and liabilities assumed for Solstas Lab Partners Group and Summit Health, Inc. acquisitions, which are further discussed below:
| Solstas |  |  |  | Summit Health |  |
Cash | $ | 572 |  |  |  |  | $ | 125 |  |  |
Estimated fair value of contingent consideration | — |  |  |  |  | 22 |  |  |
Transaction related costs due to sellers | — |  |  |  |  | 5 |  |  |
Total consideration | $ | 572 |  |  |  |  | $ | 152 |  |  |
| Solstas |  | Summit Health
| Fair Value |  | Weighted Average Useful Life (in years) |  | Fair Value |  | Weighted Average Useful Life (in years)
Allocation of purchase price: |  |  |  |  |  |  |
Cash and cash equivalents | $ | 9 |  |  |  |  | $ | 1 |  |  |
Accounts receivable, net | 48 |  |  |  |  | 9 |  |  |
Other current assets | 12 |  |  |  |  | 16 |  |  |
Property, plant and equipment, net | 49 |  |  |  |  | 6 |  |  |
Goodwill | 271 |  |  |  |  | 92 |  |  |
Intangible assets: |  |  |  |  |  |  |
Customer relationships | 203 |  |  | 20 |  | 33 |  |  | 15
Tradename | 7 |  |  | 2 |  | 2 |  |  | 1
Software | — |  |  |  |  | 3 |  |  | 4
Total intangible assets | 210 |  |  |  |  | 38 |  |  |
Non-current deferred income taxes | 48 |  |  |  |  | — |  |  |
Total assets acquired | 647 |  |  |  |  | 162 |  |  |
Current liabilities | 64 |  |  |  |  | 10 |  |  |
Non-current deferred income taxes | 3 |  |  |  |  | — |  |  |
Other non-current liabilities | 8 |  |  |  |  | — |  |  |
Total liabilities assumed | 75 |  |  |  |  | 10 |  |  |
Net assets acquired | $ | 572 |  |  |  |  | $ | 152 |  |  |
Schedule of Pro Forma Information | Pre-acquisition financial information for all other acquisitions has not been included in the table below as these acquisitions were not material to the Company’s consolidated financial statements.
| 2014
| (unaudited)
Pro forma net revenues | $ | 7,520 |
Pro forma income from continuing operations | $ | 585 |
Earnings per share attributable to Quest Diagnostics’ common stockholders - basic: |
Pro forma income from continuing operations | $ | 3.79 |
Earnings per share attributable to Quest Diagnostics’ common stockholders - diluted: |
Pro forma income from continuing operations | $ | 3.77 |

X
- Definition Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(2)-(3) -URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1392-128463 + Details
Name: | us-gaap_BusinessAcquisitionProFormaInformationTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_BusinessCombinationsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472 + Details
Name: | us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration